Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
| Conditions: | Malignant Pleural Mesothelioma |
| Start Date: | October 1, 2006 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00386815 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed|Drug: cisplatin |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Industry |
| First Received: | October 10, 2006 |
| End Date: | February 1, 2007 |
| Last Updated: | April 10, 2007 |
| Last Verified: | April 1, 2007 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
